MA25433A1 - Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux - Google Patents

Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux

Info

Publication number
MA25433A1
MA25433A1 MA26547A MA26547A MA25433A1 MA 25433 A1 MA25433 A1 MA 25433A1 MA 26547 A MA26547 A MA 26547A MA 26547 A MA26547 A MA 26547A MA 25433 A1 MA25433 A1 MA 25433A1
Authority
MA
Morocco
Prior art keywords
arylmethyl
carbonylamino
preparation
antitumor agents
thiazole derivatives
Prior art date
Application number
MA26547A
Other languages
English (en)
Inventor
Paolo Pevarello
Manuela Villa
Barbara Salom
Mario Varasi
Raffaella Amici
Anna Vulpetti
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of MA25433A1 publication Critical patent/MA25433A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MA26547A 1999-08-12 2002-03-11 Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux MA25433A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/372,832 US6114365A (en) 1999-08-12 1999-08-12 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents

Publications (1)

Publication Number Publication Date
MA25433A1 true MA25433A1 (fr) 2002-04-01

Family

ID=23469806

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26547A MA25433A1 (fr) 1999-08-12 2002-03-11 Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux

Country Status (36)

Country Link
US (3) US6114365A (fr)
EP (1) EP1204649B1 (fr)
JP (1) JP4864260B2 (fr)
KR (2) KR100827563B1 (fr)
CN (1) CN100410245C (fr)
AP (1) AP1853A (fr)
AT (1) ATE375987T1 (fr)
AU (1) AU782882B2 (fr)
BG (1) BG65484B1 (fr)
BR (1) BR0013281A (fr)
CA (1) CA2381097C (fr)
CY (1) CY1107108T1 (fr)
CZ (1) CZ303138B6 (fr)
DE (1) DE60036803T2 (fr)
DK (1) DK1204649T3 (fr)
EA (1) EA005375B1 (fr)
EE (1) EE04939B1 (fr)
ES (1) ES2295056T3 (fr)
GE (1) GEP20053475B (fr)
HK (1) HK1054233B (fr)
HR (1) HRP20020127B1 (fr)
HU (1) HUP0202492A3 (fr)
IL (2) IL147924A0 (fr)
IS (1) IS2594B (fr)
MA (1) MA25433A1 (fr)
MX (1) MXPA02001508A (fr)
NO (1) NO323576B1 (fr)
NZ (1) NZ517236A (fr)
OA (1) OA12047A (fr)
PT (1) PT1204649E (fr)
RS (1) RS50300B (fr)
SI (1) SI1204649T1 (fr)
SK (1) SK287373B6 (fr)
UA (1) UA72538C2 (fr)
WO (1) WO2001014353A1 (fr)
ZA (1) ZA200201117B (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150921A1 (en) * 1996-02-09 2002-10-17 Francis Barany Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6407103B2 (en) 1998-04-21 2002-06-18 Bristol-Myers Squibb Pharma Company Indeno [1,2-c] pyrazol-4-ones and their uses
US6320050B1 (en) * 1999-03-29 2001-11-20 Hoffmann-La Roche Inc. Heteroaromatic glucokinase activators
US6610846B1 (en) * 1999-03-29 2003-08-26 Hoffman-La Roche Inc. Heteroaromatic glucokinase activators
US7125875B2 (en) * 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
PT1169038E (pt) 1999-04-15 2012-10-26 Bristol Myers Squibb Co Inibidores cíclicos da proteína tirosina cinase
US6114365A (en) * 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
HK1049787B (en) 1999-10-01 2014-07-25 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US20040048844A1 (en) * 1999-10-20 2004-03-11 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
US6291504B1 (en) 1999-10-20 2001-09-18 Dupont Pharmaceuticals Company Acylsemicarbazides and their uses
US20040019046A1 (en) * 2000-11-27 2004-01-29 Paolo Pevarello Phenylacetamido-pyrazole derivatives and their use as antitumor agents
AU2002228692A1 (en) * 2000-12-01 2002-06-11 Bristol-Myers Squibb Pharma Company 3-(2,4-dimethylthiazol-5-yl) indeno(1,2-c)pyrazol-4-one derivatives as cdk inhibitors
JP2004538247A (ja) 2000-12-08 2004-12-24 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー セミカルバジド及びサイクリン依存キナーゼ阻害剤
ES2257461T3 (es) 2000-12-21 2006-08-01 Bristol-Myers Squibb Company Inhibidores de tiazolilo de tirosina quinasas de la familia tec.
DE60208630T2 (de) 2001-05-11 2006-08-17 Pfizer Products Inc., Groton Thiazolderivate und ihre Verwendung als cdk-Inhibitoren
EP1724270A3 (fr) 2001-07-19 2007-01-03 Pfizer Italia S.r.l. Dérivés de phenylacetamido-thiazole, leur procédé de préparation et leur utilisation en tant qu'agents antitumoraux
CZ2004107A3 (cs) * 2001-07-19 2004-04-14 Pharmacia Italia S. P. A. Fenylacetamido-thiazolové deriváty, způsob jejich přípravy a jejich použití jako protinádorových farmaceutických prostředků
ATE440094T1 (de) * 2001-09-27 2009-09-15 Equispharm Co Ltd Fumagillolderivate und verfahren zu deren herstellung
RU2374236C2 (ru) * 2001-12-21 2009-11-27 Ново Нордиск А/С Амидные производные в качестве активаторов gk
AU2003243921B2 (en) * 2002-06-27 2009-05-07 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
FR2850380B1 (fr) * 2003-01-23 2006-07-07 Sanofi Synthelabo Derives d'acylaminothiazole, leur preparation et leur utilisation en therapeutique
JP2006517577A (ja) * 2003-02-12 2006-07-27 ファイザー・インク 抗増殖性の２−（スルホ−フェニル）−アミノチアゾール誘導体
EP1597256A1 (fr) * 2003-02-21 2005-11-23 Pfizer Inc. Derives d'amino-thiazole substitues par n-heterocyclyle en tant qu'inhibiteurs de la proteine kinase
CN1794988B (zh) * 2003-03-31 2010-07-28 株式会社·R-技术上野 用于治疗血管渗透性过高疾病的组合物
WO2005014591A1 (fr) * 2003-07-15 2005-02-17 L'oreal 2-acylamino ou 2-sulfonylamino-1, 3-thiazoles en tant qu'agents de couplage pour la coloration d'oxydation de fibres keratiniques
FR2857664B1 (fr) * 2003-07-15 2007-12-14 Oreal Nouveaux derives thiazoles et utilisation de ces derives pour la teinture des fibres keratiniques
US7351727B2 (en) * 2003-09-02 2008-04-01 Bristol-Myers Squibb Company Inhibitors of 15-lipoxygenase
US20050074424A1 (en) * 2003-10-03 2005-04-07 Lev Salnikov Using polyion polymers with glucose infusion for a cancer selective chemotherapy compound and method
WO2005060956A1 (fr) * 2003-12-12 2005-07-07 University Of Maryland, Baltimore Composes immunomodulateurs de ciblage et d'inhibition du site de liaison py+3 du domaine sh2 de la proteine p56 tyrosine kinase
WO2005066145A1 (fr) 2004-01-06 2005-07-21 Novo Nordisk A/S Heteroaryl-urees et leur utilisation en tant qu'activateurs de glucokinase
JP2007517840A (ja) * 2004-01-16 2007-07-05 サノフイ−アベンテイス アシルアミノチアゾール誘導体、それらの調製方法及び治療における該誘導体の使用
EP2298291A3 (fr) 2004-06-18 2011-08-03 Agennix USA Inc. Inhibiteurs de la kinase pour le traitement de cancers
EP1621539A1 (fr) * 2004-07-27 2006-02-01 Aventis Pharma S.A. Dérivées d'urée cyclique substitués par un heterocycle, leur prépration et leur utilisation pharmaceutique comee inhibiteurs de kinases
EP1621536A1 (fr) * 2004-07-27 2006-02-01 Aventis Pharma S.A. Dérivés d'urées cycliques aminés, leur préparation et utilisation pharmaceutique en tant qu'inhibiteurs de Kinase
ES2401138T3 (es) * 2004-08-13 2013-04-17 Genentech, Inc. Inhibidores basados en tiazol de enzimas que usan ATP
EP2096107A1 (fr) 2004-12-23 2009-09-02 GPC Biotech AG Dérivés d'acide squarique dotés d'une activité anti-proliférante
US8541457B2 (en) * 2005-06-03 2013-09-24 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
ES2382815T3 (es) * 2005-07-08 2012-06-13 Novo Nordisk A/S Dicicloalquilcarbamoil ureas como activadores de glucoquinasa
US7884210B2 (en) 2005-07-14 2011-02-08 Novo Nordisk A/S Ureido-thiazole glucokinase activators
EP1914234A1 (fr) * 2006-10-16 2008-04-23 GPC Biotech Inc. Pyrido[2,3-d]pyrimidines et leur utilisation comme inhibiteurs de kinases
US8138185B2 (en) * 2007-01-09 2012-03-20 Novo Nordisk A/S Urea glucokinase activators
US8318778B2 (en) * 2007-01-11 2012-11-27 Novo Nordisk A/S Urea glucokinase activators
AU2008214679A1 (en) * 2007-02-13 2008-08-21 Ab Science Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
US8450348B2 (en) * 2007-02-21 2013-05-28 Forma Tm, Llc Derivatives of squaric acid with anti-proliferative activity
TWI437986B (zh) * 2008-01-31 2014-05-21 R Tech Ueno Ltd 噻唑衍生物及使用該衍生物作為ｖａｐ－１抑制劑之用途
US8232402B2 (en) 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
EP2112152A1 (fr) 2008-04-22 2009-10-28 GPC Biotech AG Dihydropteridinones comme inhibiteurs Plk
EP2112150B1 (fr) 2008-04-22 2013-10-16 Forma Therapeutics, Inc. Inhibiteurs Raf améliorés
CA2743717A1 (fr) 2008-11-13 2010-05-20 Link Medicine Corporation Derives d'azaquinolinone et leurs applications
UA103918C2 (en) * 2009-03-02 2013-12-10 Айерем Элелси N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
TWI504598B (zh) * 2009-03-20 2015-10-21 Onyx Therapeutics Inc 結晶性三肽環氧酮蛋白酶抑制劑
EP2440556A1 (fr) * 2009-06-10 2012-04-18 Vertex Pharmaceuticals Incorporated Inhibiteurs de la phosphatidylinositol 3-kinase
DE102009043260A1 (de) * 2009-09-28 2011-04-28 Merck Patent Gmbh Pyridinyl-imidazolonderivate
EP2325185A1 (fr) 2009-10-28 2011-05-25 GPC Biotech AG Inhibiteur de Plk
HU0900798D0 (en) 2009-12-21 2010-03-01 Vichem Chemie Kutato Kft 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
WO2012092471A2 (fr) * 2010-12-29 2012-07-05 Development Center For Biotechnology Nouveaux inhibiteurs de tubuline et procédés pour les utiliser
RU2011122942A (ru) 2011-06-08 2012-12-20 Общество С Ограниченной Ответственностью "Асинэкс Медхим" Новые ингибиторы киназ
CN103387551B (zh) * 2012-05-11 2015-05-20 中国人民解放军军事医学科学院毒物药物研究所 噻唑类化合物及其用途
ES2661717T3 (es) 2012-08-23 2018-04-03 Virostatics Srl Derivados de aminopirimidina 4,6-disustituidos novedosos
SG10202004425XA (en) 2016-04-11 2020-06-29 Genfit Methods of treatment for cholestatic and fibrotic diseases
EP3720436A4 (fr) 2017-12-06 2021-06-02 Lin Bioscience, Pty Ltd. Inhibiteurs de tubuline
CN111741944B (zh) * 2018-02-01 2025-01-03 悉尼大学 抗癌化合物
KR20210020866A (ko) 2018-06-12 2021-02-24 브이티브이 테라퓨틱스 엘엘씨 인슐린 또는 인슐린 유사체와 조합된 글루코키나제 활성제의 치료적 용도
JP2022524887A (ja) 2019-03-22 2022-05-10 ドイチェス クレブスフォルシュングスツェントルム ヒストンデアセチラーゼ１０の新規の阻害剤
EP3712127A1 (fr) 2019-03-22 2020-09-23 Deutsches Krebsforschungszentrum Nouveaux inhibiteurs de l'histone déacétylase 10
EP4015506A4 (fr) * 2019-09-25 2023-08-30 Korea Institute of Radiological & Medical Sciences Composition pour prévenir ou traiter le cancer, contenant un dérivé à base de trifluorométhylphényl pyrazole comme principe actif
JP7720059B2 (ja) * 2020-02-10 2025-08-07 学校法人順天堂 ２型リアノジン受容体活性抑制剤
WO2021167840A1 (fr) 2020-02-18 2021-08-26 Vtv Therapeutics Llc Activateurs de glucokinase sulfone et sulfoxyde et leurs procédés d'utilisation
CN115322208B (zh) * 2021-05-10 2023-04-11 中国药科大学 2-氨基噻唑类衍生物及其制备方法和医药用途
US20250206730A1 (en) * 2022-03-22 2025-06-26 Autotelic Bio Inc. Thiazole derivative compound and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL263812A (fr) * 1960-04-20
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
JPH1095777A (ja) * 1996-07-31 1998-04-14 Otsuka Pharmaceut Co Ltd チアゾール誘導体
US6794392B1 (en) * 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
US6569878B1 (en) * 1997-10-27 2003-05-27 Agouron Pharmaceuticals Inc. Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
US6040321A (en) * 1997-11-12 2000-03-21 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
CA2332325A1 (fr) * 1998-06-18 1999-12-23 Bristol-Myers Squibb Company Aminothiazole a substituant carbone, inhibiteurs de kinases dependantes de cycline
GB9823871D0 (en) * 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
PT1169038E (pt) * 1999-04-15 2012-10-26 Bristol Myers Squibb Co Inibidores cíclicos da proteína tirosina cinase
US6114365A (en) 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
US6992081B2 (en) * 2000-03-23 2006-01-31 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
SE0102440D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compound
EP1321463B1 (fr) * 2001-12-21 2007-08-08 Virochem Pharma Inc. Dérivés de thiazole et leur utilisation dans le traitement ou la prévention d'infections par des Flavivirus
TWI336696B (en) * 2003-01-27 2011-02-01 Astellas Pharma Inc Thiazole derivatives

Also Published As

Publication number Publication date
JP2003507461A (ja) 2003-02-25
IL147924A0 (en) 2002-08-14
KR20070074003A (ko) 2007-07-10
CA2381097C (fr) 2009-06-16
DE60036803T2 (de) 2008-07-24
IL147924A (en) 2008-03-20
KR100827563B1 (ko) 2008-05-07
GEP20053475B (en) 2005-03-25
NO323576B1 (no) 2007-06-11
WO2001014353A1 (fr) 2001-03-01
US6784198B1 (en) 2004-08-31
ZA200201117B (en) 2003-04-30
SK287373B6 (sk) 2010-08-09
NO20020683D0 (no) 2002-02-11
CZ2002486A3 (cs) 2002-11-13
JP4864260B2 (ja) 2012-02-01
HK1054233A1 (zh) 2003-11-21
EE04939B1 (et) 2007-12-17
SK1802002A3 (en) 2003-05-02
CZ303138B6 (cs) 2012-04-25
US20050004120A1 (en) 2005-01-06
UA72538C2 (en) 2005-03-15
DE60036803D1 (de) 2007-11-29
HUP0202492A2 (hu) 2002-11-28
YU9702A (sh) 2004-11-25
HK1054233B (zh) 2009-05-29
IS2594B (is) 2010-03-15
BG65484B1 (bg) 2008-09-30
SI1204649T1 (sl) 2008-02-29
CN1425009A (zh) 2003-06-18
CN100410245C (zh) 2008-08-13
AP1853A (en) 2008-05-29
EA005375B1 (ru) 2005-02-24
PT1204649E (pt) 2008-01-10
DK1204649T3 (da) 2007-12-03
ES2295056T3 (es) 2008-04-16
NZ517236A (en) 2004-11-26
RS50300B (sr) 2009-09-08
CA2381097A1 (fr) 2001-03-01
BR0013281A (pt) 2002-06-18
EE200200064A (et) 2003-04-15
MXPA02001508A (es) 2003-07-21
AU7440000A (en) 2001-03-19
KR100773709B1 (ko) 2007-11-09
KR20020060159A (ko) 2002-07-16
AP2002002441A0 (en) 2002-03-31
HRP20020127B1 (en) 2010-08-31
HRP20020127A2 (en) 2003-04-30
CY1107108T1 (el) 2012-10-24
EP1204649A1 (fr) 2002-05-15
EA200200247A1 (ru) 2002-08-29
NO20020683L (no) 2002-04-10
ATE375987T1 (de) 2007-11-15
OA12047A (en) 2006-05-02
BG106481A (en) 2002-09-30
PL353588A1 (en) 2003-12-01
HUP0202492A3 (en) 2004-12-28
EP1204649B1 (fr) 2007-10-17
IS6264A (is) 2002-02-11
AU782882B2 (en) 2005-09-08
US6114365A (en) 2000-09-05

Similar Documents

Publication Publication Date Title
MA25433A1 (fr) Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux
MA25493A1 (fr) Derives de 3(5)-amino-pyrazole, procede pour leur preparation et leur utilisation en tant qu'agents antitumoraux.
GB9911053D0 (en) 4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents
GB9823873D0 (en) 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
IL147925A0 (en) 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
EE200100252A (et) Pürimidiinderivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja sellevalmistamismeetod, kombinatsioon ning saadus
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
MA26831A1 (fr) Derives de benzodiazepine."
EE200200095A (et) Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
MA25223A1 (fr) Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
FR13C0008I2 (fr) Derives de phosphonocephem, leur procede de preparation et leur utilisation
CU22890A3 (es) Nuevo proceso de preparacion de derivados de fenilimidazolidina.
EP1023250A4 (fr) Procede de preparation de 2,6-dialkylnaphtalene
FR2833596B1 (fr) Procede de preparation de derives d'echinocandine
EP0990632A4 (fr) Derives d'adamantanemethanol et procede de preparation de ces derniers
FI953841A7 (fi) Substituoituja kinoliinijohdannaisia, menetelmä niiden valmistamseksi
HUP0202832A3 (en) New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
EP1092791A4 (fr) Dispersion de micelles et procede de preparation associe
MA25867A1 (fr) Procede pour la preparation de derives de pyrazolo [4,3-d] pyrimidine-7-one-3-pyridylsulfonyle, et intermediaires utilises
FR2778917B1 (fr) Nouveaux derives d'histidine, procede de preparation et utilisations
FR2786182B1 (fr) Nouveaux derives d'acylguanidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
HUP0000982A3 (en) Process for the preparation of 1,1-dioxo-penicillanic acid derivatives
FR2796963B1 (fr) Procede d'obtention de lignees isotransgeniques
FR2797443B1 (fr) Procede de prepartion de quinoleine-5,8-diones
FR2775973B1 (fr) Nouveaux derives d'histidine, procede de preparation et utilisations